ORTHOPEDIATRICS CORP — Director's Dealing 2017

Oct 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2017-10-16

Reporting Person: Throdahl Mark C (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-16	Common Stock	C	7640	—	Acquired	188282	Direct
2017-10-16	Common Stock	F	31082	$13.00	Disposed	157200	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-16	Series B Convertible Preferred Stock	$	C	11403	Disposed		Common Stock (7640)	Direct

Footnotes

F1: Represents shares received upon conversion of the Series B Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering.

F2: Each share of Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.

F3: Represents shares delivered to the Issuer to satisfy tax withholdings in connection with the lapse of restrictions on 67,877 shares of restricted common stock.